Additionally, efforts to develop mouse models of rare genetic disease entities, such as NUP98-rearranged and BCOR mutant AML have shed new mechanistic light on previously poorly understood genetic drivers and revealed novel therapeutic vulnerabilities (51, 52, 75, 77, 128). The gene discussed is NUP98; the disease is acute myeloid leukemia.